SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-19-044150
Filing Date
2019-08-06
Accepted
2019-08-06 08:13:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 a19-16584_1s3.htm S-3 417913
2 EX-4.4 a19-16584_1ex4d4.htm EX-4.4 405323
3 EX-5.1 a19-16584_1ex5d1.htm EX-5.1 38896
4 EX-23.1 a19-16584_1ex23d1.htm EX-23.1 2739
5 GRAPHIC g165841boi001.jpg GRAPHIC 4378
6 GRAPHIC g165841koi001.gif GRAPHIC 3229
7 GRAPHIC g165841bei001.gif GRAPHIC 9278
  Complete submission text file 0001104659-19-044150.txt   889661
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233038 | Film No.: 191000495
SIC: 2834 Pharmaceutical Preparations